1. Home /
  2. Fundamental Analysis

Fundamental Analysis

2 Drooping Pharma Stocks That Need to Put More Chips on the Table

Supernus Pharmaceuticals and Exelixis Inc. have the cash to be able to take some chances in order to improve their business prospects.

Here's How I'm Playing Palantir Now

Try this options strategy on PLTR's solid earnings.

Play Defense With These 6 Military Contractors

Investment experts pick their favorite stock plays for those looking to add defensive qualities to a long-term portfolio.

I'm Secure in the Belief That Cybersecurity Will Remain a Huge Investment Theme

Ransomware attacks and other cyber threats are accelerating, which means more business for companies that fight them.

This Is a Tough Environment to Forecast Rates

With so many questions around inflation, COVID, the Fed, and stimulus and policy, it's hard to determine what will happen in the rates market. Here's my take.

Restaurants Keep Beating Expectations, Though the Bar Was Set Pretty Low

The second-quarter results of most names have exceeded estimates, but the sector faces challenges ahead due to labor shortages and rising costs.

3 Healthcare Stocks for 3%+ Dividend Yields

These picks are attractive for value-oriented dividend investors looking for strong current income potential.

Should Investors Ride With Uber or Lyft?

The tale of two rideshare earnings tapes could tip the scales of opinion.

3 High-Yield Dividend Aristocrats to Buy

These names have demonstrated over a long period they have the business models and growth prospects to raise their dividend payments each year.

A Healthy Outlook for Merck and Its Organon Spinoff

Organon's management team has deep leadership, operating and financial experience.